Biomarkers Market Size, Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Japan, China, India, Brazil, Mexico, South Africa), Application Development Potential, Price Trends, Competitive Market Share & Forecast, 2019 - 2025
Report ID: GMI2733
Biomarkers Market size is projected to experience significant growth from 2018 to 2024.
Rising incidence of cancer, cardiovascular diseases, neurological disorders and other chronic diseases should increase biomarkers market growth during forecast period. Changes in dietary patterns leading to various healthcare disorders creates need for disorder detection. Large number of cancer patients suffering with various forms of cancer will further boost the demand for cancer diagnostics through biomarkers. For instance, HER-2, BRCA 1 and BRCA 2 gene biomarkers are widely being used for detection of breast cancer in women. Aforementioned factors will potentially drive the business growth over the forecast timeline.
Growing applications of biomarkers in diagnostics is projected to impel biomarkers market growth in upcoming years. Increased stress, depression levels, as well as lifestyle changes resulting into various chronic disorders and immunological disorders should escalate demand for diagnostics through biomarkers. For instance, stress is the most common form of risk factor associated with prevalence of chronic diseases. This mandates the utilizing biomarkers for investigating and treating stress-related chronic ailments, thereby utilization of biomarkers will drive the market growth.
Increasing investment in clinical trials for drug development will favor expansion of market size over the forecast timeframe owing to advantages offered by biomarkers. Biomarkers benefit clinical trials by reducing overall costs as well as making the procedures faster. They also assist in tracking efficiency of drugs thereby acting as surrogate endpoints. Better clinical trial results and greater applications in field of oncology will support industry growth in foreseeable years.
However, high investment costs and problems associated such as sample storage & collection can impair biomarkers industry growth. Moreover, unfavorable reimbursement scenario will hamper the market growth in forthcoming years.
Consumables segment is estimated to be the most lucrative segment owing to low cost of acquisition of these products in comparison with automation and screening instruments. Increasing application of biomarker consumables in personalized medicines will further boost the segment growth. Enhanced benefits in association with instruments and software will increase segmental share.
Efficacy biomarker segment is the largest revenue generating segment growing at a significant CAGR. Wide usage in oncology and antiretroviral treatment coupled with numerous research on identification of efficacy biomarkers should drive segment growth in projected timeframe.
Diagnostic biomarker segment will grow at a momentous rate owing to rising incidence of chronic diseases such as cancer, cardiovascular diseases and neurological disorders. Technological advancements along with more demand for diagnostics will greatly flourish segmental revenue size.
Cancer segment will witness a remarkable growth over the forecast period due to rising cancer prevalence across the globe. Biomarkers help in differential diagnosis, risk assessment and monitoring of disease progression in oncology field. Availability of several cancer biomarkers for detection of different kinds of cancer including ovarian cancer, breast cancer and leukemia will foster segment growth in recent years.
U.S. biomarkers market will lead biomarkers market due to favorable healthcare infrastructure as well as availability of technologically advanced products. Rising investment in drug discovery, diagnostics along with rising cancer patient pool will further stimulate the biomarkers market growth.
The major competitors of global biomarkers market include Qiagen N.V., PerkinElmer, Merck Millipore, Bio-Rad Laboratories, Enzo Biochem, EKF Diagnostics, Meso Scale Diagnostics, Biosims Technologies Sas, Cisbio Bioassays and Signosis. The companies make use of strategies such as new product development and collaborations expanding its revenue share in biomarkers market. For instance, in March 2018, PerkinElmer announced to collaborate with Nightingale Health for developing new biomarker assays that will enhance its business growth.
Biomarkers market by product, 2013-2024 (USD Million)
Biomarkers market by type, 2013-2024 (USD Million)
- Efficacy biomarkers
- Predictive biomarkers
- Surrogate biomarkers
- Pharmacodynamic biomarkers
- Prognostic biomarkers
- Safety biomarkers
- Validation biomarkers
Biomarkers market by application, 2013-2024 (USD Million)
- Disease risk assessment
- Drug discovery and development
- Personalized medicine
Biomarkers market by disease indication, 2013-2024 (USD Million)
- Cardiovascular disorders
- Neurological disorders
- Immunological disorders
The above information is provided for the following regions and countries:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
- South Africa
- Bio-Rad Laboratories
- Biosims Technologies Sas
- Cisbio Bioassays
- EKF Diagnostics
- Enzo Biochem.
- Merck Millipore
- Meso Scale Diagnostics
- Qiagen N.V.
What Information does this report contain?
Customize this Report
Our Market Research Reports Include:
- Market snapshot
- Market Segmentation
- Value Chain Analysis
- Growth Dynamics
- Potential Market Opportunities
- Regulatory Overview
- Technology Evolution
- Innovation & Sustainability
Why Global Market Insights?Comprehensive Research
- All-inclusive coverage
- In-depth and granular data (ex: information for 8 to 15 countries, with clients open to add to this list, in each report)
- Penetrative insights & latest trends
- Offers holistic understanding of the market
- Unique methodology
- Iterative in nature to eliminate errors
- Detailed methodology, scope, assumptions and data sources available for reference
- Committed to making a positive difference for our clients
- Given the nature of this industry, we are committed to ensure that our clients get maximum return on their investment in our services
- Every purchase comes with an option to obtain additional information:
- up to 10% of the original cost
- 45-minute analyst tele-call to obtain further clarity on the market.
- Global Market Insights, Inc. strictly adheres to PCI-DSS security norms.
- Only PCI-DSS compliant payment methods used for highest level of client data security
Connect with our sales team